CGN Mining climbs 6% on US nuclear deals and rising uranium prices
HK Stock Market Update·
CGN MINING
011642.0700.48% ( -0.010 )
Delay Closed: Oct 9, 16:08:06HK-Listed Firms Report Mixed Operational Data Across Diverse Sectors
Global Report·- Several Hong Kong-listed companies across sectors like pharmaceuticals, new energy, and media have released their latest operational and financial updates for 2026. - CGN Mining reported a net loss of 80,000,000 HKD due to lower uranium sales, while China Pacific Insurance achieved a net profit of 53,505,000,000 RMB with a 19.0% year-on-year growth. - Other firms like Keymed Biosciences advanced their A-share listing process and global licensing deals, whereas Star CM faced operational difficulties resulting in the suspension of satellite transmission services for its channels.Biotech's Brutal Reality Check: Big Pharma Paydays and Ignominious Exits
Global Report·- The 2026 Hong Kong pharmaceutical market presents a stark contrast as companies face intense pressure and shifting valuations. - Akeso, Simcere, and Peijia Medical achieved significant clinical successes, licensing deals, and profitability, while companies like Abbisko and NovaCentury faced severe financial distress and delisting. - This challenging economic cycle demonstrates that biotech firms must rely on solid execution and real data rather than mere storytelling to survive.